Monday, August 23, 2010

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Globe Today

Monday, August 23, 2010

Arnold breaks new work for Lee Jeans
A new campaign for Lee Jeans is just rolling out, and ads created by Arnold Worldwide of Boston feature Mike Rowe, host of the Discovery Channel TV show "Dirty Jobs," talking about how much he hates shopping and overpriced denim.

Bulkley is the new CEO of Fluidnet
Fluidnet Corp., an Amesbury company focused on advanced intravenous infusion systems, announced today that its board of directors has unanimously appointed Benjamin E. Bulkley as president and chief executive, effective immediately.

Chafee protests RI relocation deal with Schilling
PROVIDENCE -- Lincoln Chafee says he plans to attend the upcoming meeting of the state Economic Development Corporation in protest of a decision to approve a $75 million loan guarantee to Curt Schilling's video game company.

Local gas prices were unchanged
The average price for gas in Massachusetts remained unchanged at $2.689 per gallon in the latest weekly AAA survey, AAA Southern New England said today.

Who, What, Where
A sample of recent personnel announcments at local companies.

Houston chooses Kronos workforce mgt. solutions
Kronos Inc. said that the city of Houston, Texas, will use Kronos workforce management solutions to control labor costs and improve productivity.

Kimberly-Clark taps Schwartz
Schwartz Communications Inc. said it has been selected as the public relations agency of record for Kimberly-Clark Health Care, the medical device unit of Kimberly-Clark Corp.

Liberty Mutual expands presence in China
Liberty Mutual Group, a Boston-based diversified global insurer, said it has been granted approval to begin branch operations in Zhejiang by the China Insurance Regulatory Commission.

Taligen closes Series B tranche
Taligen Therapeutics, a Cambridge biotechnology company, announced that it has closed on a $10 million tranche of a Series B financing.

Today in Globe Business
A sample of Business stories from today's Globe.

No comments:

Post a Comment